127 related articles for article (PubMed ID: 9075649)
1. Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver.
Fukuda R; Ishimura N; Kushiyama Y; Moriyama N; Ishihara S; Nagasawa S; Miyake T; Niigaki M; Satoh S; Sakai S; Akagi S; Watanabe M; Fukumoto S
J Hepatol; 1997 Mar; 26(3):455-61. PubMed ID: 9075649
[TBL] [Abstract][Full Text] [Related]
2. Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus: relation to effectiveness of interferon therapy.
Fukuda R; Ishimura N; Ishihara S; Tokuda A; Satoh S; Sakai S; Akagi S; Watanabe M; Fukumoto S
J Gastroenterol; 1996 Dec; 31(6):806-11. PubMed ID: 9027643
[TBL] [Abstract][Full Text] [Related]
3. The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C.
Shindo M; Arai K; Okuno T
J Hepatol; 1997 Mar; 26(3):492-7. PubMed ID: 9075654
[TBL] [Abstract][Full Text] [Related]
4. Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection.
Morita K; Tanaka K; Saito S; Kitamura T; Kondo M; Sakaguchi T; Morimoto M; Sekihara H
J Clin Gastroenterol; 1998 Mar; 26(2):135-40. PubMed ID: 9563926
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C.
Massirer KB; Hirata MH; Silva AE; Ferraz ML; Nguyen NY; Hirata RD
Braz J Med Biol Res; 2004 May; 37(5):643-7. PubMed ID: 15107924
[TBL] [Abstract][Full Text] [Related]
6. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
Saracco G; Borghesio E; Mesina P; Solinas A; Spezia C; Macor F; Gallo V; Chiandussi L; Donada C; Donadon V; Spirito F; Mangia A; Andriulli A; Verme G; Rizzetto M
J Hepatol; 1997 Jul; 27(1):56-62. PubMed ID: 9252074
[TBL] [Abstract][Full Text] [Related]
7. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C.
Fargion S; Fracanzani AL; Sampietro M; Molteni V; Boldorini R; Mattioli M; Cesana B; Lunghi G; Piperno A; Valsecchi C; Fiorelli G
Eur J Gastroenterol Hepatol; 1997 May; 9(5):497-503. PubMed ID: 9187884
[TBL] [Abstract][Full Text] [Related]
8. Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients.
Mizukoshi E; Kaneko S; Yanagi M; Ohno H; Kaji K; Terasaki S; Shimoda A; Matsushita E; Kobayashi K
J Med Virol; 1998 Nov; 56(3):217-23. PubMed ID: 9783688
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon.
Yatsuhashi H; Yamasaki K; Aritomi T; Maria P; Carmen D; Inoue O; Koga M; Yano M
J Gastroenterol Hepatol; 1997 Jun; 12(6):460-7. PubMed ID: 9195405
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the intrahepatic expression of interferon-alpha receptor mRNA and the histological progress of hepatitis C virus-associated chronic liver diseases.
Ishimura N; Fukuda R; Fukumoto S
J Gastroenterol Hepatol; 1996 Aug; 11(8):712-7. PubMed ID: 8872766
[TBL] [Abstract][Full Text] [Related]
11. Type I interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study.
Fujiwara D; Hino K; Yamaguchi Y; Kubo Y; Yamashita S; Uchida K; Konishi T; Nakamura H; Korenaga M; Okuda M; Okita K
J Viral Hepat; 2004 Mar; 11(2):136-40. PubMed ID: 14996348
[TBL] [Abstract][Full Text] [Related]
12. IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy.
Mathai J; Shimoda K; Banner BF; Mori M; Bonkovsky HL; Barnard GF
J Interferon Cytokine Res; 1999 Sep; 19(9):1011-8. PubMed ID: 10505743
[TBL] [Abstract][Full Text] [Related]
13. Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.
Ampurdanés S; Olmedo E; Maluenda MD; Forns X; López-Labrador FX; Costa J; Sánchez-Tapias JM; de Anta MT; Rodés J
J Hepatol; 1996 Dec; 25(6):827-32. PubMed ID: 9007709
[TBL] [Abstract][Full Text] [Related]
14. Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver.
Fukuda R; Ishimura N; Hamamoto S; Moritani M; Uchida Y; Ishihara S; Akagi S; Watanabe M; Kinoshita Y
J Med Virol; 2001 Mar; 63(3):220-7. PubMed ID: 11170061
[TBL] [Abstract][Full Text] [Related]
15. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
16. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.
Shindo M; Arai K; Sokawa Y; Okuno T
Ann Intern Med; 1995 Apr; 122(8):586-91. PubMed ID: 7887552
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C.
Yatsuhashi H; Fujino T; Matsumoto T; Inoue O; Koga M; Yano M
J Hepatol; 1999 Jun; 30(6):995-1003. PubMed ID: 10406176
[TBL] [Abstract][Full Text] [Related]
18. Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices.
Bjøro K; Krarup H; Bell H; Christophersen P; Evensen S; Frøland SS; Laursen A; B vd Lippe B; Maeland A; Ranek L
Scand J Gastroenterol; 1995 Nov; 30(11):1119-24. PubMed ID: 8578174
[TBL] [Abstract][Full Text] [Related]
19. Hepatic interferon receptor mRNA expression: clinical relevance and its relationship with effectiveness of interferon plus ribavirin therapy in patients with genotype 1b hepatitis C virus infection.
Lee CM; Kee KM; Hung CH; Eng HL; Chang CH; Huang CM; Wang JH; Hu TH; Lu SN; Changchien CS; Chen WJ
Antivir Ther; 2006; 11(1):17-23. PubMed ID: 16518956
[TBL] [Abstract][Full Text] [Related]
20. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response.
Kasahara A; Hayashi N; Mochizuki K; Oshita M; Katayama K; Kato M; Masuzawa M; Yoshihara H; Naito M; Miyamoto T; Inoue A; Asai A; Hijioka T; Fusamoto H; Kamada T
J Hepatol; 1997 Mar; 26(3):574-83. PubMed ID: 9075665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
